A pivotal, randomized, cross-over, comparative pharmacokinetic study comparing ZTlido (lidocaine patch 1.8%) with Versatis (lidocaine medicated plaster 5%) in healthy subjects.
Phase of Trial: Phase III
Latest Information Update: 13 Jan 2017
At a glance
- Drugs Lidocaine (Primary) ; Lidocaine (Primary)
- Indications Postherpetic neuralgia
- Focus Pharmacokinetics
- 13 Jan 2017 New trial record
- 09 Jan 2017 Results published in the Scilex Pharmaceuticals Media Release
- 09 Jan 2017 According to a Scilex Pharmaceuticals media release, full data is planned to be filed with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom as part of a hybrid Marketing Authorization Application (MAA) in mid-2017.